Myeloid-derived suppressor cells in glioma

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Expert Review of Neurotherapeutics

• Publication date

  2013-11-12

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1586/14737175.2013.857603PMID 24215283
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Reciprocal Relationship between Myeloid-Derived Suppressor Cells and T Cells

  2013cited by this paper
• The immunosuppressive tumour network: myeloid‐derived suppressor cells, regulatory T cells and natural killer T cells

  2013cited by this paper
• Depletion of Regulatory T Cells in a Mouse Experimental Glioma Model through Anti-CD25 Treatment Results in the Infiltration of Non-Immunosuppressive Myeloid Cells in the Brain

  2013cited by this paper
• Glioma Grade Is Associated with the Accumulation and Activity of Cells Bearing M2 Monocyte Markers

  2013cited by this paper
• Coordinated regulation of myeloid cells by tumours

  2012cited by this paper
• Aptamer-mediated blockade of IL4Rα triggers apoptosis of MDSCs and limits tumor progression.

  2012cited by this paper
• Treg infiltration in glioma: a hurdle for antiglioma immunotherapy.

  2012cited by this paper
• Integration of autologous dendritic cell-based immunotherapy in the standard of care treatment for patients with newly diagnosed glioblastoma: results of the HGG-2006 phase I/II trial

  2012cited by this paper
• Oligodeoxynucleotides stabilize Helios-expressing Foxp3+ human T regulatory cells during in vitro expansion.

  2012cited by this paper
• Myeloid-derived suppressor cell measurements in fresh and cryopreserved blood samples.

  2012cited by this paper
• Myeloid-derived Suppressor Cells Adhere to Physiologic STAT3- vs STAT5-dependent Hematopoietic Programming, Establishing Diverse Tumor-Mediated Mechanisms of Immunologic Escape

  2012cited by this paper
• Myeloid-derived Suppressor Cells (MDSCs) in Gliomas and Glioma-Development

  2012cited by this paper
• Targeting natural killer cells and natural killer T cells in cancer

  2012cited by this paper
• Transcriptomic Analysis Comparing Tumor-Associated Neutrophils with Granulocytic Myeloid-Derived Suppressor Cells and Normal Neutrophils

  2012cited by this paper
• Regulatory T cells in melanoma: the final hurdle towards effective immunotherapy?

  2012cited by this paper
• Stratification according to HGG-IMMUNO RPA model predicts outcome in a large group of patients with relapsed malignant glioma treated by adjuvant postoperative dendritic cell vaccination

  2012cited by this paper
• Neuropilin 1 is expressed on thymus-derived natural regulatory T cells, but not mucosa-generated induced Foxp3+ T reg cells

  2012cited by this paper
• Neuropilin-1 distinguishes natural and inducible regulatory T cells among regulatory T cell subsets in vivo

  2012cited by this paper
• Myeloid-derived suppressor cell accumulation and function in patients with newly diagnosed glioblastoma.

  2011cited by this paper
• Signal transducer and activator of transcription 3 (Stat3C) promotes myeloid-derived suppressor cell expansion and immune suppression during lung tumorigenesis.

  2011cited by this paper
• Distinct signatures of the immune responses in low risk versus high risk neuroblastoma

  2011cited by this paper
• CD1d-Expressing Breast Cancer Cells Modulate NKT Cell-Mediated Antitumor Immunity in a Murine Model of Breast Cancer Metastasis

  2011cited by this paper
• Kinase Inhibitor Sorafenib Modulates Immunosuppressive Cell Populations in a Murine Liver Cancer Model

  2011cited by this paper
• Tumor-infiltrating myeloid cells induce tumor cell resistance to cytotoxic T cells in mice.

  2011cited by this paper
• Chronic inflammation promotes myeloid-derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma model

  2011cited by this paper
• Hallmarks of cancer: the next generation.

  2011cited by this paper
• Chemokine nitration prevents intratumoral infiltration of antigen-specific T cells

  2011cited by this paper
• Curcumin Induces the Differentiation of Myeloid-Derived Suppressor Cells and Inhibits Their Interaction with Cancer Cells and Related Tumor Growth

  2011cited by this paper
• Neutrophil Degranulation and Immunosuppression in Patients with GBM: Restoration of Cellular Immune Function by Targeting Arginase I

  2011cited by this paper
• CpG Blocks Immunosuppression by Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice

  2011cited by this paper
• Effects of antihistamine and anti‐inflammatory medication use on risk of specific glioma histologies

  2011cited by this paper
• COX-2 blockade suppresses gliomagenesis by inhibiting myeloid-derived suppressor cells.

  2011cited by this paper
• Systemic delivery of neutralizing antibody targeting CCL2 for glioma therapy

  2011cited by this paper
• Induction of CD8+ T-cell responses against novel glioma-associated antigen peptides and clinical activity by vaccinations with {alpha}-type 1 polarized dendritic cells and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in patients with recurrent malignant glioma.

  2011cited by this paper
• Tumor-infiltrating, myeloid-derived suppressor cells inhibit T cell activity by nitric oxide production in an intracranial rat glioma + vaccination model.

  2010cited by this paper
• Histamine deficiency promotes inflammation-associated carcinogenesis through reduced myeloid maturation and accumulation of CD11b+Ly6G+ immature myeloid cells

  2010cited by this paper
• Induction of Anti-Glioma Natural Killer Cell Response following Multiple Low-Dose Intracerebral CpG Therapy

  2010cited by this paper
• Transforming growth factor beta (TGF-beta) and inflammation in cancer.

  2010cited by this paper
• TGF-beta downregulates the activating receptor NKG2D on NK cells and CD8+ T cells in glioma patients.

  2010cited by this paper
• Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm

  2010cited by this paper
• Glioma-Associated Cancer-Initiating Cells Induce Immunosuppression

  2010cited by this paper
• Expression of Helios, an Ikaros Transcription Factor Family Member, Differentiates Thymic-Derived from Peripherally Induced Foxp3+ T Regulatory Cells

  2010cited by this paper
• Normal human monocytes exposed to glioma cells acquire myeloid-derived suppressor cell-like properties.

  2010cited by this paper
• Myeloid-derived suppressor cells inhibit T-cell activation by depleting cystine and cysteine.

  2010cited by this paper
• Immature immunosuppressive CD14+HLA-DR-/low cells in melanoma patients are Stat3hi and overexpress CD80, CD83, and DC-sign.

  2010cited by this paper
• Role of Type 1 IFNs in Antiglioma Immunosurveillance—Using Mouse Studies to Guide Examination of Novel Prognostic Markers in Humans

  2010cited by this paper
• HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment

  2010cited by this paper
• Sunitinib Mediates Reversal of Myeloid-Derived Suppressor Cell Accumulation in Renal Cell Carcinoma Patients

  2009cited by this paper
• Cancer-Expanded Myeloid-Derived Suppressor Cells Induce Anergy of NK Cells through Membrane-Bound TGF-β11

  2009cited by this paper
• Flow cytometry and in vitro analysis of human glioma-associated macrophages. Laboratory investigation.

  2009cited by this paper
• Myeloid-derived suppressor cells as regulators of the immune system

  2009cited by this paper
• IL4Rα+ Myeloid-Derived Suppressor Cell Expansion in Cancer Patients1

  2009cited by this paper
• Immunosuppressive Myeloid-Derived Suppressor Cells Can Be Converted into Immunogenic APCs with the Help of Activated NKT Cells: An Alternative Cell-Based Antitumor Vaccine1

  2009cited by this paper
• Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN.

  2009cited by this paper
• Modulation of Angiogenic and Inflammatory Response in Glioblastoma by Hypoxia

  2009cited by this paper
• Mechanism Regulating Reactive Oxygen Species in Tumor-Induced Myeloid-Derived Suppressor Cells1

  2009cited by this paper
• Hierarchy of immunosuppressive strength among myeloid‐derived suppressor cell subsets is determined by GM‐CSF

  2009cited by this paper
• Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.

  2009cited by this paper
• Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes.

  2009cited by this paper
• IL‐8 induces exocytosis of arginase 1 by neutrophil polymorphonuclears in nonsmall cell lung cancer

  2009cited by this paper
• Population alterations of l-arginase- and inducible nitric oxide synthase-expressed CD11b+/CD14−/CD15+/CD33+ myeloid-derived suppressor cells and CD8+ T lymphocytes in patients with advanced-stage non-small cell lung cancer

  2009cited by this paper
• Regulation of NK Cell Function by Human Granulocyte Arginase1

  2009cited by this paper
• Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor

  2009cited by this paper
• Tumor‐infiltrating myeloid‐derived suppressor cells are pleiotropic‐inflamed monocytes/macrophages that bear M1‐ and M2‐type characteristics

  2008cited by this paper
• Tumor escape mechanism governed by myeloid-derived suppressor cells.

  2008cited by this paper
• Subsets of Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice1

  2008cited by this paper
• Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity.

  2008cited by this paper
• Incidence and Prognostic Impact of FoxP3+ Regulatory T Cells in Human Gliomas

  2008cited by this paper
• Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells.

  2008cited by this paper
• The role of regulatory T cells in malignant glioma.

  2008cited by this paper
• Arginase and vascular aging.

  2008cited by this paper
• Long-term Anti-inflammatory and Antihistamine Medication Use and Adult Glioma Risk

  2008cited by this paper
• Possible involvement of the M2 anti‐inflammatory macrophage phenotype in growth of human gliomas

  2008cited by this paper
• The Interleukin-8 Pathway in Cancer

  2008cited by this paper
• Toll like receptor-3 ligand poly-ICLC promotes the efficacy of peripheral vaccinations with tumor antigen-derived peptide epitopes in murine CNS tumor models

  2007cited by this paper
• Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer

  2007cited by this paper
• Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells.

  2007cited by this paper
• Cross-Regulation between Type I and Type II NKT Cells in Regulating Tumor Immunity: A New Immunoregulatory Axis1

  2007cited by this paper
• Expansion of spleen myeloid suppressor cells represses NK cell cytotoxicity in tumor-bearing host.

  2007cited by this paper
• CD11b+Ly-6C(hi) suppressive monocytes in experimental autoimmune encephalomyelitis.

  2007cited by this paper
• L-arginine availability regulates T-lymphocyte cell-cycle progression.

  2007cited by this paper
• Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor-based antitumor vaccine.

  2007cited by this paper
• CD11b+Ly-6Chi Suppressive Monocytes in Experimental Autoimmune Encephalomyelitis1

  2007cited by this paper
• Technical hurdles in a pilot clinical trial of combined B7-2 and GM-CSF immunogene therapy for glioblastomas and melanomas

  2006cited by this paper
• The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses.

  2006cited by this paper
• CD11b+/Gr-1+ Myeloid Suppressor Cells Cause T Cell Dysfunction after Traumatic Stress1

  2006cited by this paper
• 'Pseudopalisading' Necrosis in Glioblastoma: A Familiar Morphologic Feature That Links Vascular Pathology, Hypoxia, and Angiogenesis

  2006cited by this paper
• Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression.

  2006cited by this paper
• Present and potential future issues in glioblastoma treatment

  2006cited by this paper
• All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients.

  2006cited by this paper
• Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host.

  2006cited by this paper
• CD80 in immune suppression by mouse ovarian carcinoma-associated Gr-1+CD11b+ myeloid cells.

  2006cited by this paper
• Mechanisms of malignant glioma immune resistance and sources of immunosuppression.

  2006cited by this paper
• S100A8 and S100A9 in inflammation and cancer.

  2006cited by this paper
• Increased regulatory T-cell fraction amidst a diminished CD4 compartment explains cellular immune defects in patients with malignant glioma.

  2006cited by this paper
• Interleukin-13-regulated M2 macrophages in combination with myeloid suppressor cells block immune surveillance against metastasis.

  2005cited by this paper
• Epidemiology and etiology of gliomas

  2005cited by this paper
• Cytokine Expanded Myeloid Precursors Function as Regulatory Antigen-Presenting Cells and Promote Tolerance through IL-10-Producing Regulatory T Cells1

  2005cited by this paper
• Dendritic Cell Vaccination in Glioblastoma Patients Induces Systemic and Intracranial T-cell Responses Modulated by the Local Central Nervous System Tumor Microenvironment

  2005cited by this paper
• Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors

  2005cited by this paper

• Immune Checkpoint Inhibitors and Glioblastoma: A Review on Current State and Future Directions

  2023cites this paper
• Glioma cancer stem cells modulating the local tumor immune environment

  2022cites this paper
• The multifaceted mechanisms of malignant glioblastoma progression and clinical implications

  2022cites this paper
• Systemic Delivery of an Adjuvant CXCR4-CXCL12 Signaling Inhibitor Encapsulated in Synthetic Protein Nanoparticles for Glioma Immunotherapy.

  2022cites this paper
• The roles of metabolic profiles and intracellular signaling pathways of tumor microenvironment cells in angiogenesis of solid tumors

  2022cites this paper
• Immune System-Related Changes in Preclinical GL261 Glioblastoma under TMZ Treatment: Explaining MRSI-Based Nosological Imaging Findings with RT-PCR Analyses

  2021cites this paper
• Current Approaches for Glioma Gene Therapy and Virotherapy

  2021influential citation
• Immunosuppression in Glioblastoma: Current Understanding and Therapeutic Implications

  2021cites this paper
• In Situ Deployment of Engineered Extracellular Vesicles into the Tumor Niche via Myeloid‐Derived Suppressor Cells

  2021cites this paper
• Paliperidone Inhibits Glioblastoma Growth in Mouse Brain Tumor Model and Reduces PD-L1 Expression

  2021cites this paper
• Systemic delivery of a CXCR4-CXCL12 signaling inhibitor encapsulated in synthetic protein nanoparticles for glioma immunotherapy

  2021cites this paper
• Novel Targets and Biomarkers in Solid Tumors

  2020cites this paper
• Cancer Immunoediting in Gliomas: Recent Advances and Implications for Immunotherapy.

  2020cites this paper
• Tumor‐associated macrophage interleukin‐β promotes glycerol‐3‐phosphate dehydrogenase activation, glycolysis and tumorigenesis in glioma cells

  2020cites this paper
• The Emerging Role of Myeloid-Derived Suppressor Cells in the Glioma Immune Suppressive Microenvironment

  2020cites this paper
• Explicating the Pivotal Pathogenic, Diagnostic, and Therapeutic Biomarker Potentials of Myeloid-Derived Suppressor Cells in Glioblastoma

  2020cites this paper
• The Prognostic and Therapeutic Value of PD-L1 in Glioma

  2019cites this paper
• Mesenchymal Stem Cells Derived and Cultured from Glioblastoma Multiforme Increase Tregs, Downregulate Th17, and Induce the Tolerogenic Phenotype of Monocyte-Derived Cells

  2019cites this paper
• Predictors of Response to Autologous Dendritic Cell Therapy in Glioblastoma Multiforme

  2018cites this paper
• Current state and future prospects of immunotherapy for glioma.

  2018influential citation
• Single vs. combination immunotherapeutic strategies for glioma

  2017influential citation
• Dendritic Cell Therapy for Brain Tumors

  2017cites this paper
• Checkpoint Blockade Immunotherapy for Glioblastoma

  2017cites this paper
• Immunomodulation for glioblastoma

  2017cites this paper
• Glioblastoma-synthesized G-CSF and GM-CSF contribute to growth and immunosuppression: Potential therapeutic benefit from dapsone, fenofibrate, and ribavirin

  2017cites this paper
• The Role of Myeloid-Derived Suppressor Cells in Patients with Solid Tumors: A Meta-Analysis

  2016cites this paper
• Myeloid derived suppressor cells in inflammatory conditions of the central nervous system.

  2016cites this paper
• Detection of inflammatory cell function using 13C magnetic resonance spectroscopy of hyperpolarized [6-13C]-arginine

  2016cites this paper
• Myeloid‐derived suppressor cells in gastrointestinal cancers: A systematic review

  2016cites this paper
• The Dynamics of Interactions Among Immune and Glioblastoma Cells

  2015cites this paper
• Immunosuppressive Mechanisms of Malignant Gliomas: Parallels at Non-CNS Sites

  2015influential citation
• A Systemic Review of Clinical Trials on Dendritic-Cells Based VaccineAgainst Malignant Glioma

  2015cites this paper
• Identification of glioma-associated antigens for brain tumor immunotherapy

  2015cites this paper
• FGL2 as a Multimodality Regulator of Tumor-Mediated Immune Suppression and Therapeutic Target in Gliomas.

  2015cites this paper
• Prospects of immune checkpoint modulators in the treatment of glioblastoma

  2015cites this paper
• Brain CanCer immunotherapy (review)

  2014cites this paper
• ИММУНОТЕРАПИЯ ЗЛОКАЧЕСТВЕННЫХ ОПУХОЛЕЙ ГОЛОВНОГО МОЗГА (ОбЗОР)

  2014cites this paper